EUVIMEDEUVIMED entdecken
Crossref

Involvement of microglia‐expressed MS4A6A in the onset of glioblastoma

Wenhao Lv iD, Shengyan Lin, Zhenxing Zuo, Zhihui Huang, Yongjie Wang iD

European Journal of Neuroscience · 2024

DOI: 10.1111/ejn.16309 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2024. Verfasst von Wenhao Lv und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Microglia, Membrane Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Medical Science and Technology Project of Zhejiang Province, Natural Science Foundation of Zhejiang Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma multiforme (GBM) represents the deadliest form of brain tumour, characterized by its low survival rate and grim prognosis. Cytokines released from glioma‐associated microglia/macrophages are involved in establishing the tumour microenvironment, thereby crucially promoting GBM progression. MS4A6A polymorphism was confirmed to be associated with neurodegenerative and polymorphism disease pathobiology, but whether it participates in the regulation of GBM and the underlying mechanisms is still not elucidated. Here, we found that MS4A6A was significantly upregulated in GBM patient samples. The results from the single‐cell RNA‐sequencing (scRNA‐seq) database and immunostaining demonstrated the specific expression of MS4A6A in microglial cells. In vitro, microglial overexpression of MS4A6A stimulated the proliferation and migration of glioblastoma cells. Moreover, high MS4A6A mRNA expression was related to poor prognosis in GBM patients. Our study highlights the potential of MS4A6A as a promising biomarker for GBM, which may provide novel strategies for its prevention, diagnosis and treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaMicrogliaMembrane ProteinsHumansBiomarkers, TumorCell Line, TumorCell MovementCell ProliferationGene Expression Regulation, NeoplasticPrognosisTumor Microenvironment

Stichwörter der Autor:innen

MS4A6Aglioblastoma multiformemicrogliamigrationproliferation

Substanzen

Biomarkers, TumorMS4A6A protein, humanMembrane Proteins

Autor:innen und Institutionen

  • School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
  • School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, Zhejiang, China.
  • Department of Neurosurgery, Tenth people's Hospital, Tongji University School of Medicine, Shanghai, China.

ORCID-Profile: Wenhao Lv, Yongjie Wang

Förderung

  • Medical Science and Technology Project of Zhejiang Province
  • Natural Science Foundation of Zhejiang Province
  • National Natural Science Foundation of China
  • National College Students Innovation and Entrepreneurship Training Program

Zitieren

APA

Lv, W., Lin, S., Zuo, Z., Huang, Z., & Wang, Y. (2024). Involvement of microglia‐expressed MS4A6A in the onset of glioblastoma. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16309

Vancouver

Lv W, Lin S, Zuo Z, Huang Z, Wang Y. Involvement of microglia‐expressed MS4A6A in the onset of glioblastoma. European Journal of Neuroscience. 2024. doi:10.1111/ejn.16309

BibTeX
@article{Lv2024,
  author = {Lv, Wenhao and Lin, Shengyan and Zuo, Zhenxing and Huang, Zhihui and Wang, Yongjie},
  title = {Involvement of microglia‐expressed MS4A6A in the onset of glioblastoma},
  journal = {European Journal of Neuroscience},
  year = {2024},
  doi = {10.1111/ejn.16309}
}
Kostenlos starten →